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Juvenile myoclonic epilepsy (JME) has a distinct clinical profile. Often JME is not recognized, with the result that proper
treatment is not instituted, leading to poor control of seizures. This study is an attempt to identify the factors that contribute to
the delay in diagnosing this condition. During a period of 3 years 40 patients (21 females) with JME were identified and all were
included in a prospective follow-up study. The age range was 12–58 years. Twenty-seven patients (67%) had already seen at
least one specialist; however, diagnosis had not been made despite the presence of characteristic features. The duration of delay
in diagnosis varied from months to years with a mean of 11 years. Myoclonic jerks were the most characteristic feature, but
only six volunteered this information spontaneously. The response to treatment with sodium valproate was excellent, although
only three were taking it when first seen. As a result of treatment with other drugs all patients were having recurrent seizures.
The main reasons for the delay in diagnosis found in our study were that the physicians were unaware of the condition, the
occurrence of myoclonic jerks were overlooked either because the patients were not directly questioned about them or because
the patients did not volunteer the information.
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INTRODUCTION
A major advance in epileptology has been the recog-
nition of epileptic syndromes with distinct aetiology,
clinical features, treatment and prognosis. The best
example for the importance of the syndrome classi-
fication is juvenile myoclonic epilepsy (JME), a pri-
mary generalized epilepsy with an onset around 12–
18 years. The following features distinguish the dis-
order from the other epilepsies: all patients have my-
oclonic seizures, about 80% of patients have general-
ized tonic–clonic seizures in addition, while absence
seizures are less commonly seen in about 25%. My-
oclonic jerks are common on awakening and charac-
teristically seizures are precipitated by sleep depriva-
tion, alcohol consumption and flickering lights. Phys-
ical examination is normal and CT scan of the brain is
normal. Electroencephalography (EEG) shows charac-
teristic paroxysms of generalized polyspikes and slow
waves. Complete remission is seen in over 80% of
those treated with the appropriate drug, but there is a
high relapse rate on stopping treatment1. Juvenile my-
oclonic epilepsy accounts for about 5–10% of cases
of epilepsy worldwide and a rate of 11.4% has been
reported from Sri Lanka2. Despite clinical and EEG
features that should enable its easy identification, the
rate of misdiagnosis remains high worldwide3, 4. The
aim of this study was to find out the extent and fac-
tors responsible for missing this diagnosis in a group
of patients with epilepsy in Sri Lanka.
MATERIALS AND METHODS
Over a period of 3 years, from January 1991 to Decem-
ber 1993, 40 patients with JME were identified and in-
cluded in a prospective follow-up study. The diagnosis
of JME was made using well-defined clinical and EEG
criteria1. The patients were referred by general prac-
titioners, outpatient departments, general physicians
and psychiatrists, while some were direct self refer-
rals. A pre-tested, validated questionnaire was filled in
for each patient at the first visit and updated at each
follow-up visit.
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RESULT
Of the 40 patients, 21 were female and 19 were male.
The ages of the patients at the first visit ranged from
12 to 58 years (mean 25.9, SD 11). The age at on-
set of the first manifestations of the disease ranged
from 10 to 37 years (mean 16.4, SD 5). The first
manifestation reported was generalized tonic–clonic
seizures in 28, falls in four, dropping objects in four,
and jerks in eight. Myoclonic jerks were present in
all patients, but, only six volunteered the informa-
tion. In 23 patients the myoclonic jerks were ob-
served characteristically on waking in the morning,
more so if it was earlier than usual. The patients re-
ported these jerks as shivers, falls and dropping things.
The most difficult was when they assumed that the
myoclonic jerks were the beginning of a generalized
tonic–clonic seizure which did not go on to become
a full-blown seizure. Surprisingly, absence seizures
were not reported by any patient in this series, even af-
ter direct questioning. Sleep deprivation was the com-
monest precipitating cause in these patients, seen in
27 (68%) patients. Other precipitants included stress
arithmetic in one, alcohol in one, and menstruation in
one. A normal EEG was seen in 14 patients, while
in 17 patients it was abnormal and of them seven
had paroxysms of polyspikes and slow waves. The
EEG was not available in nine patients. Fourteen pa-
tients were on two antiepileptic drugs and three pa-
tients were on three. The drugs being taken by pa-
tients were: phenobarbitone, 15; phenytoin, 14; car-
bamazepine, 10; sodium valproate, three. The previ-
ous diagnoses which have been made by the attend-
ing doctors were: epilepsy, 24; grand mal epilepsy,
five; petit mal, two; migraine, one; no definite diagno-
sis, eight. The mean delay in diagnosis was 11 years.
Only five patients had their diagnosis made during
the first year. In 11 patients there was a delay of up
to 5 years, in 12 it took between 5 and 10 years, in
seven patients between 11 and 20 years, and in five
patients over 20 years. The longest time interval was
43 years. Probable reasons for the delayed diagnosis
were: patients not complaining of myoclonic jerks,
34; the EEG changes not characteristic, 10; the doc-
tor unaware of the syndrome at least in 28 of the
patients who had both tonic–clonic seizures and my-
oclonic jerks. Except for the four first timers, all the
patients had been seen by a doctor for treatment of
the fits prior to the first visit to the hospital clinic.
Nine had seen only a general practitioner, while 27
had taken treatment from a specialist (general physi-
cians, neurologists, neurosurgeons, psychiatrists, and
an ENT surgeon) without a proper diagnosis having
been made.
DISCUSSION
Failure to recognize JME may result in uncontrolled
seizures, status epilepticus, social and educational fail-
ure and even death. Misdiagnosis of JME has been
reported from West Germany, USA, UK and Saudi
Arabia. The main reason for missing the diagnosis is
that the patients rarely complain of myoclonic jerks.
Though all our patients admitted to having myoclonic
jerks on detailed specific questioning, only six vol-
unteered this information without any prompting. Pa-
tients tend to interpret the myoclonic jerks in many
different ways and many do not complain of them be-
cause they think it is part of a tonic–clonic seizure.
Patients usually interpret the jerks as falls, shivers
and dropping of objects and the significance of these
symptoms can easily be overlooked. The best way to
elicit a history of myoclonic jerks was to demonstrate
it to the patient.
Absence seizures have been reported in up to 25% of
JME patients, but none of our patients admitted to hav-
ing them. This could be for many reasons—ours is an
adult population and absence seizures are more com-
mon during childhood; patients are likely to ignore or
forget these minor lapses in the presence of myoclonic
jerks and seizures; it is also known that absences in
JME are so mild that they may even go unnoticed and
may even be mistaken as complex partial seizures.
The most effective anticonvulsant in this condition
is sodium valproate1. Clonazepam may be added if
myoclonic jerks are not well controlled, though the
use of clonazepam alone may not control the tonic–
clonic seizures5. Phenytoin and phenobarbitone may
have some effect, but carbamazepine is not effective.
In this series only three patients were on sodium val-
proate when they were first seen by us. However, even
these three patients were not receiving adequate doses
of the drug and as a result the fits were poorly con-
trolled in all 40 patients.
This study shows that the following factors con-
tribute to the delayed diagnosis of JME. Physicians are
unaware of this syndrome and its high prevalence, a
history of myoclonic jerks is not elicited because the
physician does not specifically ask for them in the his-
tory, and even when the patient experiences such jerks,
they interpret them as shakes or nervousness in the
morning.
Thus, it is recommended that physicians looking af-
ter patients with epilepsy must consider JME as the
diagnosis if the onset of epilepsy is around puberty
or in the teens, there is poor control of the fits even
when adequate doses of carbamazepine are given, and
when the fits are precipitated by sleep deprivation. The
physician must specifically question the patient about
the presence of myoclonic jerks in patients with fits
who are in the appropriate age group.
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